Table 1.
Overview of clinical samples used for the study.
| Donors | Age | FPHL Grade * | Scalp Region | Source | Experiment | |
|---|---|---|---|---|---|---|
| Healthy donors | 1 | 45 | - | occipital | skin | in situ immunostaining |
| 2 | 24 | - | occipital | skin | in situ immunostaining | |
| 3 | 40 | - | occipital | skin | in situ immunostaining | |
| 4 | 48 | - | occipital | FUEs | metabolic activity | |
| 5 | 54 | - | occipital | FUEs | metabolic activity | |
| 6 | 26 | - | occipital | FUEs | metabolic activity | |
| FPHL patients | 1 | 50 | I | occipital and parietal | skin | in situ immunostaining |
| 2 | 54 | II | occipital and parietal | skin | in situ immunostaining | |
| 3 | 62 | II | occipital and parietal | skin | in situ immunostaining | |
| 4 | 28 | II | parietal | skin | in situ immunostaining | |
| 5 | 60 | I | occipital and parietal | skin | in situ immunostaining | |
| 6 | 35 | II–III | occipital and parietal | FUEs | UPLC-MS | |
| 7 | 53 | II | occipital and parietal | FUEs | UPLC-MS | |
| 8 | 30 | I | occipital and parietal | FUEs | UPLC-MS | |
| 9 | 70 | Ludwig III | occipital and parietal | FUEs | ex vivo absorption | |
| 10 | 43 | Ludwig II | occipital and parietal | FUEs | metabolic activity/ex vivo absorption | |
| 11 | 65 | Sinclair II | occipital and parietal | FUEs | metabolic activity/ex vivo absorption | |
| 12 | 53 | Sinclair II–III | occipital and parietal | FUEs | metabolic activity/ex vivo absorption | |
| 13 | 42 | Sinclair III | occipital and parietal | FUEs | metabolic activity/ex vivo absorption | |
* scales to clinically score FPHL disease severity; FPHL = Female pattern hair loss; FUEs = Follicular unit extractions; UPLC-MS = Ultra Performance Liquid Chromatography-Mass Spectrometry.